Athens Medical C.S.A. Market Cap ($139.94 Million)
Market Cap & Net Worth: Athens Medical C.S.A. (IATR)
Athens Medical C.S.A. market cap. Athens Medical C.S.A. (AT:IATR) has a market capitalization of $139.94 Million (€119.70 Million) as of October 31, 2026. Listed on the AT stock exchange, this Greece-based company holds position #17732 globally and #50 in its home market, demonstrating a -4.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Athens Medical C.S.A.'s stock price €1.38 by its total outstanding shares 86735980 (86.74 Million).
Athens Medical C.S.A. Market Cap History (2015–2026)
Athens Medical C.S.A. market cap history from 2015 to 2026. Data shows growth from $59.10 Million to $139.94 Million (6.99% CAGR). Check Athens Medical C.S.A. stock price for real-time trading data and today's change.
Athens Medical C.S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Athens Medical C.S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see IATR operating cash flow for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.57x
Athens Medical C.S.A.'s market cap is 0.57 times its annual revenue
Latest Price to Earnings (P/E) Ratio
85.79x
Athens Medical C.S.A.'s market cap is 85.79 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $59.10 Million | $158.09 Million | -$15.77 Million | 0.37x | N/A |
| 2016 | $58.12 Million | $167.35 Million | $3.47 Million | 0.35x | 16.76x |
| 2017 | $141.45 Million | $169.27 Million | $2.63 Million | 0.84x | 53.86x |
| 2018 | $96.88 Million | $182.75 Million | $10.76 Million | 0.53x | 9.00x |
| 2019 | $204.42 Million | $197.27 Million | $7.59 Million | 1.04x | 26.94x |
| 2020 | $147.74 Million | $187.50 Million | $3.92 Million | 0.79x | 37.65x |
| 2021 | $163.73 Million | $226.00 Million | $15.05 Million | 0.72x | 10.88x |
| 2022 | $143.99 Million | $233.42 Million | $6.85 Million | 0.62x | 21.03x |
| 2023 | $187.09 Million | $258.36 Million | $8.08 Million | 0.72x | 23.15x |
| 2024 | $152.61 Million | $269.85 Million | $1.78 Million | 0.57x | 85.79x |
Competitor Companies of IATR by Market Capitalization
Companies near Athens Medical C.S.A. in the global market cap rankings as of October 31, 2026. See IATR equity financing ratio to understand what proportion of total assets are financed by equity.
Key companies related to Athens Medical C.S.A. by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of Athens Medical C.S.A. (2015–2026)
Market capitalization of Athens Medical C.S.A. from 2015 to today. Between 2015 and today, Athens Medical C.S.A.'s market cap moved from $59.10 Million to $ 139.94 Million, with a yearly change of 6.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €139.94 Million | -30.30% |
| 2025 | €200.78 Million | +31.56% |
| 2024 | €152.61 Million | -18.43% |
| 2023 | €187.09 Million | +29.93% |
| 2022 | €143.99 Million | -12.05% |
| 2021 | €163.73 Million | +10.82% |
| 2020 | €147.74 Million | -27.72% |
| 2019 | €204.42 Million | +111.00% |
| 2018 | €96.88 Million | -31.51% |
| 2017 | €141.45 Million | +143.35% |
| 2016 | €58.12 Million | -1.65% |
| 2015 | €59.10 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Athens Medical C.S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $139.94 Million USD |
| MoneyControl | $139.94 Million USD |
| MarketWatch | $139.94 Million USD |
| marketcap.company | $139.94 Million USD |
| Reuters | $139.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Athens Medical C.S.A.
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and … Read more